E-LIB Suche - Ergebnisse für: Zhou, Caicun

1

Camrelizumab plus famitinib in previously chemo-immunothera..:

Ren, Shengxiang ; Xiong, Anwen ; Yu, Jia...
Cancer Immunology, Immunotherapy. 73 (2024) 7 - p. , 2024

Link: https://doi.org/10.1007/..

2

Paclitaxel therapeutic drug monitoring - International asso..:

Hertz, Daniel L. ; Joerger, Markus ; Bang, Yung-Jue...
European Journal of Cancer. 202 (2024) - p. 114024 , 2024

Link: https://doi.org/10.1016/..

3

First-line treatment with camrelizumab plus famitinib in ad..:

Ren, Shengxiang ; Wang, Xicheng ; Han, Bao-Hui...
Journal for ImmunoTherapy of Cancer. 12 (2024) 2 - p. e007227 , 2024

Link: https://doi.org/10.1136/..

4

Canakinumab in combination with docetaxel compared with doc..:

Paz-Ares, Luis ; Goto, Yasushi ; Wan-Teck Lim, Darren...
Lung Cancer. 189 (2024) - p. 107451 , 2024

Link: https://doi.org/10.1016/..

5

Targeting focal adhesion kinase boosts immune response in K..:

Qiao, Meng ; Zhou, Fei ; Liu, Xinyu...
Experimental Hematology & Oncology. 13 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

6

A global phase 3 study of serplulimab plus chemotherapy as ..:

Zhou, Caicun ; Hu, Yanping ; Arkania, Ekaterine...
Cancer Cell. 42 (2024) 2 - p. 198-208.e3 , 2024

Link: https://doi.org/10.1016/..

7

Comparison of the somatic genomic landscape between central..:

Wang, Lei ; Diao, Meng ; Zhang, Zheng...
Lung Cancer. 187 (2024) - p. 107439 , 2024

Link: https://doi.org/10.1016/..

8

Single‐cell transcriptomics reveal metastatic CLDN4+ cancer..:

Zhang, Xiaoshen ; Wang, Xuanhe ; Wen, Yaokai...
Clinical and Translational Medicine. 14 (2024) 4 - p. , 2024

Link: https://doi.org/10.1002/..

9

NTRK gene fusion testing and management in lung cancer:

Repetto, Matteo ; Chiara Garassino, Marina ; Loong, Herbert H....
Cancer Treatment Reviews. 127 (2024) - p. 102733 , 2024

Link: https://doi.org/10.1016/..

10

Publisher Correction: Interim survival analysis of the rand..:

Zhou, Caicun ; Wang, Ziping ; Sun, Meili...
Nature Cancer. 5 (2024) 1 - p. 209-209 , 2024

Link: https://doi.org/10.1038/..

11

A Phase 1b Study of Ivonescimab, a Programmed Cell Death Pr..:

Wang, Lei ; Luo, Yongzhong ; Ren, Shengxiang...
Journal of Thoracic Oncology. 19 (2024) 3 - p. 465-475 , 2024

Link: https://doi.org/10.1016/..

12

Osimertinib in combination with anti-angiogenesis therapy p..:

Han, Ruoshuang ; Guo, Haoyue ; Shi, Jinpeng...
BMC Medicine. 22 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

13

Induction immunochemotherapy followed by definitive chemora..:

Wu, Leilei ; Cheng, Bo ; Sun, Xiaojiang...
MedComm. 5 (2024) 3 - p. , 2024

Link: https://doi.org/10.1002/..

14

Identifying optimal ALK inhibitors in first- and second-lin..:

Zhao, Mingye ; Shao, Taihang ; Shao, Hanqiao..
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

15

Clinical activity of pembrolizumab with or without chemothe..:

Song, Lianxi ; Zhou, Fei ; Xu, Tian...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..